BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10853019)

  • 1. A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas.
    Kin Y; Chintala SK; Go Y; Sawaya R; Mohanam S; Kyritsis AP; Rao JS
    Int J Oncol; 2000 Jul; 17(1):61-5. PubMed ID: 10853019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells.
    Mohan PM; Lakka SS; Mohanam S; Kin Y; Sawaya R; Kyritsis AP; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1999; 17(7):617-21. PubMed ID: 10845561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.
    Mohan PM; Chintala SK; Mohanam S; Gladson CL; Kim ES; Gokaslan ZL; Lakka SS; Roth JA; Fang B; Sawaya R; Kyritsis AP; Rao JS
    Cancer Res; 1999 Jul; 59(14):3369-73. PubMed ID: 10416596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
    Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA.
    Mohanam S; Chintala SK; Mohan PM; Sawaya R; Lagos GK; Gokaslan ZL; Kouraklis GP; Rao JS
    Int J Oncol; 1998 Dec; 13(6):1285-90. PubMed ID: 9824646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
    Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors.
    Go Y; Chintala SK; Mohanam S; Gokaslan Z; Venkaiah B; Bjerkvig R; Oka K; Nicolson GL; Sawaya R; Rao JS
    Clin Exp Metastasis; 1997 Jul; 15(4):440-6. PubMed ID: 9219733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death.
    Nalabothula N; Lakka SS; Dinh DH; Gujrati M; Olivero WC; Rao JS
    Int J Oncol; 2007 Mar; 30(3):669-78. PubMed ID: 17273768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells.
    Yanamandra N; Konduri SD; Mohanam S; Dinh DH; Olivero WC; Gujrati M; Nicolson GL; Obeyeseke M; Rao JS
    Clin Exp Metastasis; 2000; 18(7):611-5. PubMed ID: 11688967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma cells deficient in urokinase plaminogen activator receptor expression are susceptible to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
    Krishnamoorthy B; Darnay B; Aggarwal B; Dinh DH; Kouraklis G; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2001 Dec; 7(12):4195-201. PubMed ID: 11751520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.
    Mohanam S; Gladson CL; Rao CN; Rao JS
    Front Biosci; 1999 Feb; 4():D178-87. PubMed ID: 9989951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
    Adachi Y; Chandrasekar N; Kin Y; Lakka SS; Mohanam S; Yanamandra N; Mohan PM; Fuller GN; Fang B; Fueyo J; Dinh DH; Olivero WC; Tamiya T; Ohmoto T; Kyritsis AP; Rao JS
    Oncogene; 2002 Jan; 21(1):87-95. PubMed ID: 11791179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor.
    Chintala SK; Mohanam S; Go Y; Venkaiah B; Sawaya R; Gokaslan ZL; Rao JS
    Mol Carcinog; 1997 Dec; 20(4):355-65. PubMed ID: 9433480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.